510-74-7
510-74-7 結(jié)構(gòu)式
基本信息
螺拉米特
AMI-193
spiramide
Fluroxyspiramine
8-[3-(4-FLUOROPHENOXY)PROPYL]-1-PHENYL-1,3,8-TRIAZASPIRO[4.5]-DECANONE
8-[3-(4-FLUOROPHENOXY)PROPYL]-1-PHENYL-1,3,8-TRIAZASPIRO[4.5]DECAN-4-ONE
1-Phenyl-8-[3-(4-fluorophenoxy)propyl]-1,3,8-triazaspiro[4.5]decane-4-one
1,3,8-Triazaspiro[4.5]decan-4-one, 8-[3-(4-fluorophenoxy)propyl]-1-phenyl-
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2024/11/08 | HY-100971 | 螺哌丙苯 Spiramide | 510-74-7 | 5mg | 800元 |
| 2024/11/08 | HY-100971 | 螺哌丙苯 Spiramide | 510-74-7 | 10mM * 1mLin DMSO | 880元 |
| 2024/11/08 | HY-100971 | 螺哌丙苯 Spiramide | 510-74-7 | 10mg | 1300元 |
常見問題列表
|
5-HT 2 Receptor 2 nM (Ki) |
D 2 Receptor 3 nM (Ki) |
5-HT 1A Receptor 50 nM (Ki) |
D 1 Receptor 2530 nM (Ki) |
5-HT 1C Receptor 4300 nM (Ki) |
Spiramide retains affinity for 5-HT 1A sites (K i =50 nM) and also binds at dopamine D2 sites (K i =3 nM), but possesses low affinity for dopamine D1 sites (K i =2530 nM).
AMI-193 (0.003-0.01 mg/kg; i.m.) dose-dependently decreases response rate in monkeys under a fixed-interval (FI) schedule of stimulus termination.
AMI-193 (0.003-0.01 mg/kg; i.m.) attenuates the discriminative-stimulus effects of cocaine in drug-discrimination experiments.
AMI-193 (0.003-0.01 mg/kg; i.m.) reduces response rate under a second-order schedule of i.v. self-administration of cocaine (0.1 mg/infusion).
| Animal Model: | Adult male squirrel monkeys (850-1300 g) |
| Dosage: | 0.003, 0.01 mg/kg |
| Administration: | I.m. on Tuesday, Wednesday, and Thursday the following week |
| Result: |
Decreased the response rate.
The rate-decreasing effects were reversed by cocaine. |